Category Archives: Co-morbidities

Review of electrocardiographic abnormalities among people living with HIV in Sub-Saharan Africa: A systematic review

2023

INTRODUCTION: Electrocardiographic (ECG) abnormalities are increasingly being reported among people living with HIV (PLWH). However, the exact prevalence of ECG abnormalities among PLWH in Sub-Saharan Africa (SSA), a region with...

A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus

2023

People living with human immunodeficiency virus (HIV) (PLWH) appear to be at an increased risk of sarcopenia, which can have a devastating effect on their life due to consequences such...

Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis

2023

Background: HIV continues to be a major global health issue. The relative risk of cardiovascular disease (CVD) among people living with HIV (PLWH) was 2.16 compared to non-HIV-infections. The prediction of...

Selected inflammatory and coagulation biomarkers pre-viral suppression in people with human immunodeficiency virus (HIV) infection without overt cardiovascular disease: Is there a need to redefine reference indices?

2023

Background Human immunodeficiency virus (HIV) infection is prevalent in Africa and causes morbidity and mortality despite antiretroviral therapy (ART). Non-communicable complications of HIV infection include cardiovascular disease (CVD) with thromboses throughout the vascular tree....

Performance of cardiovascular risk prediction models among people living with HIV: A systematic review and meta-analysis

2023

Importance  Extant data on the performance of cardiovascular disease (CVD) risk score models in people living with HIV have not been synthesized. Objective  To synthesize available data on the performance of the...

Cardiovascular disease risk in women living with HIV

2022

PURPOSE OF REVIEW: To synthesize current evidence on the impact of cardiovascular disease among women living with HIV (WLWH) with a particular focus on disease prevalence, mechanisms and prevention. RECENT...

Prevention of heart failure, tachyarrhythmias and sudden cardiac death in HIV

2022

PURPOSE OF REVIEW: To summarize the state-of-the-art literature on the epidemiology, disease progression, and mediators of heart failure, tachyarrhythmias, and sudden cardiac death in people living with HIV (PLWH) to...

Addressing gaps in cardiovascular care for people with HIV: Bridging scientific evidence and practice

2022

PURPOSE OF REVIEW: People with HIV continue to have an excess burden of cardiovascular disease compared to the general population. The reasons for these disparities in cardiovascular disease include HIV-specific...

The effect of antiretroviral therapy on the periodontal conditions of patients with HIV infection: A systematic review and meta-analysis

2023

Aim: To assess any differences (1) in the prevalence of periodontitis and necrotizing periodontal diseases, specifically necrotizing gingivitis (NG) and necrotizing periodontitis (NP) between HIV patients receiving antiretroviral therapy (HAART) and...

Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: A systematic review and meta-analysis

2022

Background: Globally, the human immunodeficiency virus has been recognized as a major public health concern. The direct toxicity of antiretroviral medicines or their active metabolites causes liver cell destruction by different...

A systematic review of four decades of prevalence of oral soft tissue infections and conditions among adult HIV patients in India

2022

Oral lesions are a cue for decreased immunity among Human Immunodeficiency Virus (HIV) positive patients. There is no cumulative data available related to the prevalence of oral soft tissue lesions...

Risk of myocardial infarction in HIV patients: A systematic review

2022

Human immunodeficiency virus (HIV) is a retrovirus that is associated with mortality in the final stage. The advancement of antiretroviral therapy (ART) improved the life expectancy of patients with HIV....

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!